Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Mach7 Technologies ( (AU:M7T) ) is now available.
Mach7 Technologies has notified the market of the lapse and cessation of 133,335 options that were subject to conditional rights over its securities. These options, which expired at various dates and exercise prices, ceased on 17 February 2026 and 27 February 2026 after the specified conditions were not met or became incapable of being satisfied.
The adjustment slightly reduces Mach7’s pool of outstanding equity-linked instruments, clarifying its issued capital structure for investors. While the announcement is largely administrative, it signals that certain performance or vesting conditions tied to these options were not achieved, which may inform stakeholders’ views on prior incentive programs and future capital management flexibility.
The most recent analyst rating on (AU:M7T) stock is a Hold with a A$0.28 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited is an Australian-listed company in the medical imaging and health technology sector, trading on the ASX under the code M7T. The company is known for providing enterprise imaging solutions and related software that support healthcare providers in managing, storing, and accessing medical images and diagnostic content across clinical workflows.
Average Trading Volume: 275,274
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$69.33M
Learn more about M7T stock on TipRanks’ Stock Analysis page.